e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Assessment and management of immune-mediated interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Longitudinal cost of care in individuals with different subtypes of interstitial lung diseases
L. Schwarzkopf (Neuherberg, Germany), S. Witt (Neuherberg, Germany), J. Wälscher (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany)
Source:
International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Session:
Assessment and management of immune-mediated interstitial lung diseases
Session type:
Thematic Poster
Number:
4732
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Schwarzkopf (Neuherberg, Germany), S. Witt (Neuherberg, Germany), J. Wälscher (Heidelberg, Germany), M. Kreuter (Heidelberg, Germany). Longitudinal cost of care in individuals with different subtypes of interstitial lung diseases. 4732
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases)
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Prevalence and characteristics of cystic lung lesions in children with interstitial lung diseases – a register-based study
Source: Virtual Congress 2021 – Paediatric bronchology
Year: 2021
Intensive care outcomes in patients with diffuse fibrotic parenchymal lung diseases
Source: Annual Congress 2011 - Intensive care outcome
Year: 2011
Benefits from a program for “early interstitial lung diseases” in primary care centers
Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases
Year: 2017
Health care resources utilisation and costs in patients with non-IPF progressive fibrosing interstitial lung disease
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
EPIDIA: an App to to assist physicians in the care of patients with interstitial lung diseases
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021
The management of children with interstitial lung disease
Source: International Congress 2018 – Difficult paediatric lung disease
Year: 2018
The effectiveness of pulmonary rehabilitation in interstitial lung diseases in terms of functional markers
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018
Epidemiological profile of chronic interstitial lung diseases in Tunisian patients
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
The internet-based network for the management of children with interstitial lung disease
Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease
Year: 2014
Medication for childhood interstitial lung diseases differs internationally
Source: International Congress 2018 – Orphan diseases in children
Year: 2018
Associations between comorbidities and survival in patients with interstitial lung diseases
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021
A comparison of existing questionnaires for identifying the causes of interstitial and rare lung diseases
Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Year: 2019
Genetic studies in paediatric interstitial lung disease
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012
The future of treatment for interstitial lung diseases: the patient’s and physician’s perspective
Source: International Congress 2019 – Rare lung diseases
Year: 2019
Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases – a claims data analysis
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018
Quality of life in patients of interstitial lung diseases from India
Source: Eur Respir J 2005; 26: Suppl. 49, 540s
Year: 2005
Air travel for patients with interstitial lung diseases
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009
Why should we care for the vessels in interstitial lung disease?
Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases
Year: 2020
Progressive fibrosing interstitial lung diseases (PF-ILDs): prevalence and characterization in two Italian referral centers
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept